Spongy degeneration of the central nervous system (van Bogaert and Bertrand type; Canavan's disease). A review.
Canavan Disease.
Nagy A, Bley AE, Eichler F.
1999 Sep 16 [updated 2023 Dec 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Leukodystrophy Imaging: Insights for Diagnostic Dilemmas.
Thakkar RN, Patel D, Kioutchoukova IP, Al-Bahou R, Reddy P, Foster DT, Lucke-Wold B.
Med Sci (Basel). 2024 Jan 25;12(1):7. doi: 10.3390/medsci12010007.
Spongy degeneration of the central nervous system (van Bogaert and Bertrand type; Canavan's disease). A review.
Adachi M, Schneck L, Cara J, Volk BW.
Hum Pathol. 1973 Sep;4(3):331-47. doi: 10.1016/s0046-8177(73)80098-x.
Canavan Disease.
Bokhari MR, Samanta D, Bokhari SRA.
2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials.
Metovic J, Li Y, Gong Y, Eichler F.
Neurotherapeutics. 2024 Jul;21(4):e00443. doi: 10.1016/j.neurot.2024.e00443. Epub 2024 Sep 13.
Spongy degeneration of the brain, Canavan disease: biochemical and molecular findings.
Matalon RM, Michals-Matalon K.
Front Biosci. 2000 Mar 1;5:D307-11. doi: 10.2741/matalon.
Alexander Disease.
Hartog L, Dekeyzer S, Bossche SV.
J Belg Soc Radiol. 2021 Oct 21;105(1):61. doi: 10.5334/jbsr.2588. eCollection 2021.
Leukodystrophies.
Perlman SJ, Mar S.
Adv Exp Med Biol. 2012;724:154-71. doi: 10.1007/978-1-4614-0653-2_13.
Neuroglia in leukodystrophies.
Hol EM, Dykstra W, Chevalier J, Cuadrado E, Bugiani M, Aronica E, Verkhratsky A.
Handb Clin Neurol. 2025;210:159-175. doi: 10.1016/B978-0-443-19102-2.00032-6.
The pathogenesis of, and pharmacological treatment for, Canavan disease.
Wei H, Moffett JR, Amanat M, Fatemi A, Tsukamoto T, Namboodiri AM, Slusher BS.
Drug Discov Today. 2022 Sep;27(9):2467-2483. doi: 10.1016/j.drudis.2022.05.019. Epub 2022 May 27.
